Performance analysis of LENZ Therapeutics (LENZ)
Annual Return
Over the past 3 years, LENZ has had an average annual return of -27.55%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, LENZ has had an average annual return of -47.22%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Jun 25, 2021, LENZ has had an average annual return of -43.46%, underperforming the benchmark SPY, which returned +13.21% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -67.77% | -44.58% | +119.07% | -21.11% | -73.28% | -32.81% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.11% | -14.71% | -32.21% | -1.83% | -13.37% | -27.03% | -9.18% | -67.77% | |||||
| 2025 | -11.57% | -14.47% | +17.77% | +10.89% | +2.42% | +0.38% | +1.56% | +29.76% | +20.57% | -36.18% | +2.69% | -47.59% | -44.58% |
| 2024 | +3.81% | +24.63% | +31% | -28.96% | -3.64% | +13.09% | +43.60% | -5.81% | +1.51% | +13.56% | +32.03% | -18.90% | +119.07% |
| 2023 | -35.26% | +22.38% | -6.89% | +30.21% | -10.96% | -8.47% | -2.63% | -12.28% | +11.75% | +0.37% | -8.84% | +15.40% | -21.11% |
| 2022 | -24.85% | -1.51% | -44.56% | -21.18% | -41.56% | +17.01% | +14.60% | +5.05% | -4.19% | +10.68% | +0.58% | -5.92% | -73.28% |
| 2021 | +66.11% | -30.49% | -8.52% | -16.12% | -22.27% | -29.19% | +37.80% | -32.81% |
Drawdown analysis of LENZ Therapeutics (LENZ)
The maximum drawdown for the LENZ was -96.85%, occurring on Jul 16, 2026. This drawdown has not yet recovered.
The current LENZ drawdown is -96.66%.
Since Jun 25, 2021 LENZ has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.85% | Jun 30, 2021 | 1265 | Jul 16, 2026 | Ongoing | Ongoing | Ongoing |